TrialThe Journal of infectious diseases2017

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.

Holly E Janes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.